Jo-Anne Young
,
Credentials
MD

Professor of Medicine, Division of Infectious Diseases and International Medicine
Biography

Bio

Administrator Info
Name: IDIM Admin
Phone: 612-624-9996
Email: idimdivision@umn.edu
Fax: 612-625-4410
Mail: 420 Delaware Street SE
MMC 250, Room D416 Mayo
Memorial Building
Minneapolis, MN 55455

Summary
Jo-Anne Young (née van Burik), M.D., is a Professor of Medicine and Medical Director of the Program in Adult Transplant Infectious Disease. She joined the faculty in 1999. She received both her B.A. and M.D. from Case Western Reserve University and completed a residency in Medicine at Vanderbilt University Medical Center. Her fellowship in Infectious Disease and several years of junior faculty service were at the University of Washington with the Fred Hutchinson Cancer Research Center. Dr. Young's primary area of interest is bringing diagnostic and treatment opportunities to the bedside for transplant patients. She has worked on developing diagnostic testing for complicated fungal infections of the immunocompromised host. Currently, Dr. Young is lead investigator at the University of Minnesota for multiple clinical trials on bacterial, viral, and fungal agents, as well as vaccines, for transplant patients.

Clinical Summary

  • Viral infections
  • Fungal infections
  • Transplant recipients
  • Immune compromised persons

Education

MD, Case Western Reserve University School of Medicine

Honors and Recognition

Best Doctors for Women, Minnesota Monthly
2014
Best Doctor, Minnesota Monthly
2014
Best Doctors in America

Professional Memberships

Clinical Microbiology Reviews, Editor-in-Chief
Selected Publications

Selected Publications

Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR, Alangaden GJ, Brown JM, Fredricks DN Heinz WJ, Herbrecht R, Klimko N, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Racil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruatanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, and Vehreschild MJ; VITAL and FungiScope Mucormycosis Investigators. (2016) Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infectious Disease 16(7):828-37.,
Ballen K, Woo Ahn K, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin MJ, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JH, Auletta J, Komanduri KV, Lindemans C, Riches ML. (2016) Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplant 22(9):1636-45.,
Gea-Banacloche J, Komanduri KV, Carpenter P, Paczesny S, Sarantopoulos S, Young JA, El Kassar N, Le RQ, Schultz KR, Griffith LM, Savani BN, Wingard JR. (2016) National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Biology of Blood and Marrow Transplant Oct 14. pii: S1083-8791(16)30391-3.,
Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JH, Bennett JE. (2016) Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Disease 63(4):433-42 (executive summary) and e1-e60.,
Khoruts A, Hippen KL, Lemire AM, Holtan SG, Knights D, Young JH. (2017) Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota. Translational Research. 2017 Jan;179:116-125.,